HPC
EW icon

HM Payson & Co’s Edwards Lifesciences EW Stock Holding History

HM Payson & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$599K Hold
6,621
– – 0.01% 283
2026
Q1 		$530K Hold
6,621
– – 0.01% 293
2025
Q4 		$564K Sell
6,621
-100
-1% -$8.21K 0.01% 278
2025
Q3 		$523K Hold
6,721
– – 0.01% 284
2025
Q2 		$526K Sell
6,721
-400
-6% -$29.8K 0.01% 280
2025
Q1 		$516K Buy
7,121
+200
+3% +$14.3K 0.01% 282
2024
Q4 		$512K Sell
6,921
-312
-4% -$21.8K 0.01% 275
2024
Q3 		$477K Buy
7,233
+1,128
+18% +$82K 0.01% 293
2024
Q2 		$564K Buy
6,105
+22
+0.4% +$1.95K 0.01% 263
2024
Q1 		$581K Hold
6,083
– – 0.01% 265
2023
Q4 		$464K Buy
6,083
+125
+2% +$8.7K 0.01% 284
2023
Q3 		$413K Buy
5,958
+2,040
+52% +$164K 0.01% 285
2023
Q2 		$370K Sell
3,918
-240
-6% -$20.9K 0.01% 297
2023
Q1 		$344K Sell
4,158
-1,276
-23% -$100K 0.01% 304
2022
Q4 		$405K Buy
5,434
+567
+12% +$43.7K 0.01% 271
2022
Q3 		$402K Sell
4,867
-450
-8% -$43.3K 0.01% 266
2022
Q2 		$506K Sell
5,317
-14
-0.3% -$1.45K 0.01% 248
2022
Q1 		$628K Buy
5,331
+144
+3% +$16.2K 0.01% 245
2021
Q4 		$672K Sell
5,187
-348
-6% -$40.6K 0.01% 249
2021
Q3 		$627K Buy
5,535
+1,198
+28% +$137K 0.02% 253
2021
Q2 		$449K Hold
4,337
– – 0.01% 281
2021
Q1 		$363K Sell
4,337
-147
-3% -$12.4K 0.01% 304
2020
Q4 		$409K Hold
4,484
– – 0.01% 282
2020
Q3 		$358K Buy
4,484
+680
+18% +$53.1K 0.01% 282
2020
Q2 		$263K Hold
3,804
– – 0.01% 304
2020
Q1 		$239K Hold
3,804
– – 0.01% 294
2019
Q4 		$296K Hold
3,804
– – 0.01% 330
2019
Q3 		$279K Hold
3,804
– – 0.01% 330
2019
Q2 		$234K Buy
+3,804
New +$230K 0.01% 368

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

HM Payson & Co's EW Position: Q2 2026 in Review

HM Payson & Co held its Edwards Lifesciences (EW) position steady in Q2 2026 at 6,621 shares worth $599K. The position accounts for 0.01% of the portfolio, ranked #283.

HM Payson & Co first reported a position in EW in Q2 2019 and has held it in 29 quarters since. The position peaked at $672K in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • HM Payson & Co held 6,621 shares of Edwards Lifesciences worth $599K as of Q2 2026.
  • HM Payson & Co left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.01% of HM Payson & Co's portfolio in Q2 2026, its #283 holding.
  • HM Payson & Co first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 29 quarters since.
  • HM Payson & Co's Edwards Lifesciences position peaked at $672K in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.